• Learning Objective 1:Describe treatment modalities of metastatic hormone positive breast cancer.
• Learning Objective 2:Discuss key clinical trials in this group of patients.
• Learning Objective 3:Discuss future directions of treatment.

AND

Learning Objective 1:Prognostic differences between HPV positive and HPV negative oropharyngeal cancers

• Learning Objective 2:Pathogenesis and genetic differences of HPV positive oropharyngeal cancer
• Learning Objective 3:Basis for de-escalation of treatment for HPV positive oropharyngeal cancer